SCOPUS 정보 검색 플랫폼

Drug Information Journal

Volumn 40, Issue 4, 2006, Pages 437-444

Implementing adaptive designs: Logistical and operational considerations

(2) Quinlan, Judith A a Krams, Michael b,c

a GLAXOSMITHKLINE (United Kingdom)

b Wyeth (United States)

c Clinical Development (United States)

Author keywords

Adaptive Design; Drug supply; Electronic data capture; Modeling

Indexed keywords

ADAPTIVE DESIGN; ARTICLE; DECISION MAKING; DRUG INDUSTRY; DRUG MANUFACTURE; EDUCATION; FEASIBILITY STUDY; INFORMATION PROCESSING; METHODOLOGY; MODEL; ORGANIZATION; PLANNING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROFESSIONAL STANDARD; RISK BENEFIT ANALYSIS; SIMULATION; STANDARDIZATION;

EID: 33750893179 PISSN: 00928615 EISSN: None Source Type: Journal
DOI: 10.1177/216847900604000409 Document Type: Article

Times cited : (59)

References (10)

1
- 33750854113
- Adaptive seamless phase II/III designs-background, operational aspects, and examples
- Maca J, Bhattacharya S, Dragalin V, Gallo P, Krams M. Adaptive seamless phase II/III designs-background, operational aspects, and examples. Drug Inf J. 2006;40:463-474.
- (2006) Drug Inf J , vol.40 , pp. 463-474
- Maca, J.¹ Bhattacharya, S.² Dragalin, V.³ Gallo, P.⁴ Krams, M.⁵

2
- 24944501851
- ASTIN: A Bayesian adaptive dose-response trial in acute stroke
- Grieve AP, Krams M. ASTIN: a Bayesian adaptive dose-response trial in acute stroke. Clin Trials. 2005;2:340-351.
- (2005) Clin Trials , vol.2 , pp. 340-351
- Grieve, A.P.¹ Krams, M.²

3
- 3242669861
- Statistical innovations in oncology
- Holland J, Frei E, Kufe D, et al., eds. London: Decker
- Berry DA. Statistical innovations in oncology. In Holland J, Frei E, Kufe D, et al., eds. Cancer Medicine. 6th ed. London: Decker; 2003:465-487
- (2003) Cancer Medicine. 6th Ed. , pp. 465-487
- Berry, D.A.¹

4
- 32044450843
- Adaptive designs for dose-finding based on efficacy-toxicity response
- Dragalin V, Fedorov V. Adaptive designs for dose-finding based on efficacy-toxicity response. J Stat Plann inference. 2006;136:1800-1823.
- (2006) J Stat Plann Inference , vol.136 , pp. 1800-1823
- Dragalin, V.¹ Fedorov, V.²

5
- 4444272419
- Dose-finding based on efficacy-toxicity trade-offs
- Thall PF, Cook JD. Dose-finding based on efficacy-toxicity trade-offs. Biometrics. 2004;60:684-693.
- (2004) Biometrics , vol.60 , pp. 684-693
- Thall, P.F.¹ Cook, J.D.²

6
- 33750861611
- Adaptive dose-response finding studies
- Gaydos B, Bedding A, Berry D, et al. Adaptive dose-response finding studies. Drug Inf J. 2006;40:451-461.
- (2006) Drug Inf J , vol.40 , pp. 451-461
- Gaydos, B.¹ Bedding, A.² Berry, D.³

7
- 0012792209
- Chichester, UK: Wiley
- Ellenberg SE, Fleming TR, DeMets DL. Data Monitoring Committees in Clinical Trials: A Practical Perspective. Chichester, UK: Wiley; 2002.
- (2002) Data Monitoring Committees in Clinical Trials: A Practical Perspective
- Ellenberg, S.E.¹ Fleming, T.R.² Demets, D.L.³

8
- 0347236586
- US Food and Drug Administration. Rockville, MD: US Food and Drug Administration
- US Food and Drug Administration. Guidance for Clinical Trial Sponsors on the Establishment and Operation of Clinical Trial Data Monitoring Committees. Rockville, MD: US Food and Drug Administration; 2006.
- (2006) Guidance for Clinical Trial Sponsors on the Establishment and Operation of Clinical Trial Data Monitoring Committees

9
- 33745128497
- Committee for Medicinal Products for Human Use. London: EMEA
- Committee for Medicinal Products for Human Use. Guideline on Data Monitoring Committees. London: EMEA; 2005.
- (2005) Guideline on Data Monitoring Committees

10
- 33750884934
- Regulatory confidentiality issues for adaptive design trials
- Gallo P. Regulatory confidentiality issues for adaptive design trials. Drug Inf J. 2006;40:445-450.
- (2006) Drug Inf J , vol.40 , pp. 445-450
- Gallo, P.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.